KK Noevir Holdings

4928

Equity

ISIN JP3760450001 / Valor 11962363

Tokyo Stock Exchange (2024-09-13)

JPY 5,340.00+1.91%

KK Noevir Holdings
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

KK Noevir Holdings is a diversified Japanese company specializing in the development, production, and sale of a wide range of skincare, cosmetics, and health-related products. The company operates through various sales channels, including direct sales via representatives, its own retail stores, and online platforms. Its flagship skincare brand, Noevir, is known for high-performance, prestige products, while its self-selection cosmetics, such as the Namerakahonpo skincare line, excel makeup line, and NOV hypoallergenic cosmetics, are marketed through general retailers and online stores. In addition to cosmetics, Noevir Holdings offers over-the-counter pharmaceuticals, including cough drops, cold remedies, and eye drops, as well as nutritional supplements and health foods. The company also engages in contract manufacturing of cosmetics and quasi-drugs, leveraging its extensive industry expertise.

Summarized from source with an LLMView SourceSector: Healthcare

Net Sales

KK Noevir Holdings reported net sales of 48,238 million yen for the first nine months of the fiscal year ending September 30, 2024, reflecting a 2.9% increase compared to the same period in the previous year. This growth was driven primarily by the performance in the Cosmetics segment.

Operating Income

Operating income for KK Noevir Holdings in the first nine months of fiscal 2024 reached 9,015 million yen, marking a 2.7% increase year-on-year. This improvement was attributed to effective cost management and increased sales in key segments.

Ordinary Income

KK Noevir Holdings achieved an ordinary income of 9,169 million yen for the first nine months of fiscal 2024, which represents a 2.3% rise from the previous year. The steady growth in ordinary income underscores the company's robust operational performance.

Net Income

Net income attributable to owners of the parent for KK Noevir Holdings was 4,490 million yen for the first nine months of fiscal 2024, a decrease of 4.4% compared to the same period last year. This decline was mainly due to higher expenses and strategic investments made during the period.

Dividends

KK Noevir Holdings has maintained its annual dividend forecast at 220.00 yen per share for the fiscal year ending September 30, 2024. This decision reflects the company's commitment to returning value to its shareholders while balancing growth and investment needs.

Summarized from source with an LLMView Source

Key figures

-5.82%1Y

-12.2%3Y

-7.13%5Y

Performance

16.3%1Y

18.4%3Y

21.8%5Y

Volatility